Boundary events: Contact-dependent and contact-facilitated signaling between platelets

Seminars in Thrombosis and Hemostasis

Volumn 30, Issue 4, 2004, Pages 399-410

  Brass, Lawrence F ^a   Stalker, Timothy J ^a   Zhu, Li ^a   Lu, Boxun ^a   Woulfe, Donna S ^a   Prevost, Nicolas ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cell adhesion molecules; Contact dependent signaling; Eph kinases; Integrins; Outside in signaling; Platelet activation; Receptor tyrosine kinases

Indexed keywords

CD40 LIGAND; CELL ADHESION MOLECULE; EPHRIN; GROWTH ARREST SPECIFIC PROTEIN 6; INTEGRIN; PROTEIN TYROSINE KINASE;

CARBOXY TERMINAL SEQUENCE; CELL ADHESION; CELL INTERACTION; CELL MIGRATION; CELL SURFACE; ENDOTHELIUM CELL; GENE CLUSTER; GLYCOSYLATION; HEMOSTASIS; HUMAN; MONOCYTE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTOPOIESIS; THROMBOGENESIS; THROMBUS;

ANIMALS; BLOOD PLATELETS; CELL ADHESION MOLECULES; CELL COMMUNICATION; HUMANS; MODELS, BIOLOGICAL; PLATELET ACTIVATION; PLATELET AGGREGATION; SIGNAL TRANSDUCTION;

EID: 4444340242     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-833475     Document Type: Review

References (116)

1. Humbert M, Nurden P, Bihour C, et al. Ultrastructural studies of platelet aggregates from human subjects receiving clopidogrel and from a patient with an inherited defect of an ADP-dependent pathway of platelet activation. Arterioscler Thromb Vasc Biol 1996;16:1532-1543
2. White JG. Interaction of membrane systems in blood platelets. Am J Pathol 1972;66:295-312
3. White JG. Platelet membrane ultrastructure and its changes during platelet activation. Prog Clin Biol Res 1988;283:1-32
4. Skaer RJ, Emmines JP, Skaer HB. The fine structure of cell contacts in platelet aggregation. J Ultrastruct Res 1979;69:28-42
5. Payrastre B, Missy K, Trumel C, Bodin S, Plantavid M, Chap H. The integrin alphaIIb/beta3 in human platelet signal transduction. Biochem Pharmacol 2000;60:1069-1074
6. Philips DR, Prasad KSS, Manganello J, Bao M, Nannizzi-Alaimo L. Integrin tyrosine phosphorylation in platelet signaling. Curr Opin Cell Biol 2001;13:546-554
7. Phillips DR, Nannizzi-Alamio L, Prasad KSS. Beta3 tyrosine phosphorylation in alphaIIbbeta3 (platelet membrane GP IIb-IIIa) outside-in integrin signaling. Thromb Haemost 2001;86:246-258
8. Obergfell A, Eto K, Mocsai A, et al. Coordinate interactions of Csk, Src and Syk kinases with alphaIIbbeta3 initiate integrin signaling to the cytoskeleton. J Cell Biol 2002;157:265-275
9. Guinebault C, Payrastre B, Racaud-Sultan C, et al. Integrin-dependent translocation of phosphoinositide 3-kinase to the cytoskeleton of thrombin-activated platelets involves specific interactions of p85alpha with actin filaments and focal adhesion kinase. J Cell Biol 1995;129:831-842
10. Shattil SJ, O'Toole T, Eigenthaler M, et al. Beta3-endonexin, a novel polypeptide that interacts specifically with the cytoplasmic tail of the integrin beta3 subunit. J Cell Biol 1995;131:807-816
11. Naik UP, Patel PM, Parise LV. Identification of a novel calcium-binding protein that interacts with the integrin alphallb cytoplasmic domain. J Biol Chem 1997;272:4651-4654
12. Shock DD, Naik UP, Brittain JE, Alahari SK, Sondek J, Parise LV. Calcium-dependent properties of CIB binding to the integrin alphaIIb cytoplasmic domain and translocation to the platelet cytoskeleton. Biochem J 1999;342:729-735
13. Calderwood DA, Zent R, Grant R, Rees DJ, Hynes RO, Ginsberg MH. The talin head domain binds to integrin beta subunit cytoplasmic tails and regulates integrin activation. J Biol Chem 1999;274:28071-28074
14. Gao J, Zoller KE, Ginsberg MH, Brugge JS, Shattil SJ. Regulation of the pp72syk protein tyrosine kinase by platelet integrin alphaIIbbeta3. EMBO J 1997;16:6414-6425
15. Woodside DG, Obergfell A, Leng L, et al. Activation of Syk protein tyrosine kinase through interaction with integrin beta cytoplasmic domains. Curr Biol 2001;11:1799-1804
16. Jenkins AL, Nannizzi-Alaimo L, Silver D, et al. Tyrosine phosphorylation of the beta3 cytoplasmic domain mediates integrin-cytoskeletal interactions. J Biol Chem 1998;273:13878-13885
17. Cowan KJ, Law DA, Phillips DR. Identification of She as the primary protein binding to the tyrosine-phosphorylated beta3 subunit of alphaIIbbeta3 during outside-in integrin platelet signaling. J Biol Chem 2000;275:36423-36429
18. Tadokoro S, Shattil SJ, Eto K, et al. Talin binding to integrin beta tails: a final common step in integrin activation. Science 2003;302:103-106
19. Law DA, DeGuzman FR, Heiser P, Ministri-Madrid K, Killeen N, Phillips DR. Integrin cytoplasmic tyrosine motif is required for outside-in alphaIIbbeta3 signaling and platelet function. Nature 1999;401:808-811
20. Elrod JW, Park JH, Oshima T, Sharp CD, Minagar A, Alexander JS. Expression of junctional proteins in human platelets. Platelets 2003;14:247-251
21. Muller WA. Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response. Trends Immunol 2003;24:327-334
22. Bazzoni G. The JAM family of junctional adhesion molecules. Curr Opin Cell Biol 2003;15:525-530
23. Ostermann G, Weber KS, Zernecke A, Schroder A, Weber C. JAM-1 is a ligand of the beta(2) integrin LFA-1 involved in transendothelial migration of leukocytes. Nat Immunol 2002;3:151-158
24. Santoso S, Sachs UJ, Kroll H, et al. The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1. J Exp Med 2002;196:679-691
25. Kornecki E, Walkowiak B, Naik UP, Ehrlich YH. Activation of human platelets by a stimulatory monoclonal antibody. J Biol Chem 1990;265:10042-10048
26. Naik UP, Ehrlich YH, Kornecki E. Mechanisms of platelet activation by a stimulatory antibody: cross-linking of a novel platelet receptor for monoclonal antibody F11 with the Fc gamma RII receptor. Biochem J 1995;310(pt 1):155-162
27. Babinska A, Kedees MH, Athar H, et al. F11-receptor (F11R/JAM) mediates platelet adhesion to endothelial cells: role in inflammatory thrombosis. Thromb Haemost2002;88:843-850
28. Ozaki H, Ishii K, Arai H, et al. Junctional adhesion molecule (JAM) is phosphorylated by protein kinase C upon platelet activation. Biochem Biophys Res Commun 2000;276:873-878
29. Hirata K, Ishida T, Penta K, et al. Cloning of an immunoglobulin family adhesion molecule selectively expressed by endothelial cells. J Biol Chem 2001;276:16223-16231
30. Nasdala I, Wolburg-Buchholz K, Wolburg H, et al. A transmembrane tight junction protein selectively expressed on endothelial cells and platelets. J Biol Chem 2002;277:16294-16303
31. Ishida T, Kundu RK, Yang E, Hirata K, Ho YD, Quertermous T. Targeted disruption of endothelial cell-selective adhesion molecule inhibits angiogenic processes in vitro and in vivo. J Biol Chem 2003;278:34598-34604
32. Scott JL, Dunn SM, Jin B, et al. Characterization of a novel membrane glycoprotein involved in platelet activation. J Biol Chem 1989;264:13475-13482
33. Kojima H, Kanada H, Shimizu S, et al. CD226 mediates platelet and megakaryocytic cell adhesion to vascular endothelial cells. J Biol Chem 2003;278:36748-36753
34. Shibuya A, Lanier LL, Phillips JH. Protein kinase C is involved in the regulation of both signaling and adhesion mediated by DNAX accessory molecule-1 receptor. J Immunol 1998;161:1671-1676
35. Bottino C, Castriconi R, Pende D, et al. Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J Exp Med 2003;198:557-567
36. Prevost N, Woulfe D, Tanaka T, Brass LF. Interactions between Eph kinases and ephrins provide a novel mechanism to support platelet aggregation once cell-to-cell contact has occurred. Proc Natl Acad Sci USA 2002;99:9219-9224
37. Prevost N, Fortna R, Tognolini M, Woulfe D, Wu J, Brass LF. Contact-dependent signaling by Eph kinases and ephrins promotes the late phases of platelet activation, including clot retraction. Blood 2002;100:477a
38. Woulfe D, Prevost N, Jiang H, Tognolini M, Fortna R, Brass LF. Eph receptor-ephrin interactions contribute to the tyrosine phosphorylation of the cytoplasmic domain of the beta subunit of alphaIIbbeta3 during platelet aggregation. Blood 2002;100:477a
39. Prevost N, Woulfe DS, Tognolini M, et al. Signaling by ephrinB1 and Eph kinases in platelets promotes Rap1 activation, platelet adhesion and aggregation via effector pathways that do not require phosphorylation of ephrinB1. Blood 2004;103:1348-1355
40. Gale NW, Holland SJ, Valenzuela DM, et al. Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis. Neuron 1996;17:9-19
41. Klein R. Excitatory Eph receptors and adhesive ephrin ligands. Curr Opin Cell Biol 2001;13:196-203
42. Dodelet VC, Pasquale EB. Eph receptors and ephrin ligands: embryogenesis to tumorigenesis. Oncogene 2000;19:5614-5619
43. Gerety SS, Wang HU, Chen Z-F, Anderson DJ. Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development. Mol Cell 1999;4:403-414
44. Adams RH, Wilkinson GA, Weiss C, et al. Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis and sprouting angiogenesis. Genes Dev 1999;13: 295-306
45. Adams RH, Klein R. Eph receptors and ephrin ligands: essential mediators of vascular development. Trends Cardiovasc Med 2000;10:183-188
46. Himanen JP, Henkemeyer M, Nikolov DB. Crystal structure of the ligand binding domain of the receptor tyrosine kinase EphB2. Nature 1998;396:486-491
47. Toth J, Cutforth T, Gelinas AD, Bethoney KA, Bard J, Harrison CJ. Crystal structure of an ephrin ectodomain. Dev Cell 2001;1:83-92
48. Kalo MS, Yu HH, Pasquale EB. In vivo tyrosine phosphorylation sites of activated ephrin-B1 and EphB2 from neural tissues. J Biol Chem 2001;276:38940-38948
49. Torres R, Firestein BL, Dong HL, et al. PDZ proteins bind, cluster, and synaptically colocalize with Eph receptors and their ephrin ligands. Neuron 1998;21:1453-1463
50. Lin D, Gish GD, Songyang Z, Pawson T. The carboxyl terminus of B class ephrins constitutes a PDZ binding motif. J Biol Chem 1999;274:3726-3733
51. Bruckner K, Pablo Labrador J, Scheiffele P, Herb A, Seeburg PH, Klein R. EphrinB ligands recruit GRIP family PDZ adaptor proteins into raft membrane microdomains. Neuron 1999;22:511-524
52. Della Rocca GJ, Van Biesen T, Daaka Y, Luttrell DK, Luttrell LM, Lefkowitz RJ. Ras-dependent mitogen-activated protein kinase activation by G protein-coupled receptors - convergence of Gi- and Gq-mediated pathways on calcium/calmodulin, Pyk2, and Src kinase. J Biol Chem 1997;272:19125-19132
53. Himanen JP, Rajashankar KR, Lackmann M, Cowan CA, Henkemeyer M, Nikolov DB. Crystal structure of an Eph receptor-ephrin complex. Nature 2001;414:933-938
54. Huynh-Do U, Stein E, Lane AA, Liu H, Cerretti DP, Daniel TO. Surface densities of ephrin-B1 determine EphB1-coupled activation if cell attachment through alphavbeta3 and alpha5beta1 integrins. EMBO J 1999;18: 2165-2173
55. Holland SJ, Gale NW, Gish GD, et al. Juxtamembrane tyrosine residues couple the Eph family receptor EphB2/ Nuk to specific SH2 domain proteins in neuronal cells. EMBO J 1997;16:3877-3888
56. Hock B, Bohme B, Karn T, et al. PDZ-domain-mediated interaction of the Eph-related receptor tyrosine kinase EphB3 and the ras-binding protein AF6 depends on the kinase activity of the receptor. Proc Natl Acad Sci USA 1998;95:9779-9784
57. Dodelet VC, Pazzagli C, Zisch AH, Hauser CA, Pasquale EB. A novel signaling intermediate, SHEP1, directly couples Eph receptors to R-Ras and Rap1A. J Biol Chem 1999;274: 31941-31946
58. Pandey A, Duan H, Dixit VM. Characterization of a novel src-like adapter protein that associates with the Eck receptor tyrosine kinase. J Biol Chem 1995;270:19201-19204
59. Cowan CA, Henkemeyer M. The SH2/SH3 adaptor Grb4 transduces B-ephrin reverse signals. Nature 2001;413:174-179.
60. Birgbauer E, Cowan CA, Sretavan DW, Henkemeyer M. Kinase independent function of EphB receptors in retinal axon pathfinding to the optic disc from dorsal but not ventral retina. Development 2000;127:1231-1241
61. Buchert M, Schneider S, Meskenaite V, et al. The junction-associated protein AF-6 interacts and clusters with specific Eph receptor tyrosine kinases at specialized sites of cell-cell contact in the brain. J Cell Biol 1999;144:361-371
62. Holland SJ, Gale NW, Mbamalu G, Vancopoulos GD, Henkemeyer M, Pawson T. Bidirectional signaling through the the EPH-family receptor Nuk and its transmembrane ligands. Nature 1996;383:722-725
63. Palmer A, Zimer M, Erdmann KS, et al. Ephrin B phosphorylation and reverse signaling: regulation by Src kinases and PTP-BL phosphatase. Mol Cell 2002;9:725-737
64. Xu Z, Kwok-On L, Zhou H-M, Lin S-C, Ip NY. Ephrin-B1 reverse signaling activates JNK through a novel mechanism that is independent of tyrosine phosphorylation. J Biol Chem 2003;278:24767-24775
65. Schultz J, Ponting CP, Hofmann K, Bork P. SAM as a protein interaction domain involved in developmental regulation. Protein Sci 1997;6:249-253
66. Thanos CD, Goodwill KE, Bowie JU. Oligomeric structure of the human Ephb2 receptor SAM domain. Science 1999; 283:833-836
67. Stapleton D, Balan L, Pawson T, Sicheri F. The crystal structure of an Eph receptor SAM domain reveals a mechanism for modular dimerization. Nat Struct Biol 1999;6:44-49
68. Smalla M, Schmieder P, Kelly M, et al. Solution structure of the receptor tyrosine kinase EphB2 SAM domain and identification of two distinct homotypic interaction sites. Protein Sci 1999;8:1954-1961
69. Wilkinson DG. Eph receptors and ephrins: regulators of guidance and assembly. Int Rev Cytol 2000;196:177-244
70. Gale NW, Yancopoulos GD. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev 1999;13:1055-1066
71. Kullander K, Klein R. Mechanisms and function of Eph and ephrin signaling. Nat Rev Mol Cell Biol 2002;3:475-486
72. Sakano S, Serizawa R, Inada T, et al. Characterization of a ligand for receptor protein-tyrosine kinase HTK expressed in immature hematopoietic cells. Oncogene 1996;13:813-822
73. Inada T, Iwama A, Sakano S, Ohno M, Sawada K, Suda T. Selective expression of the receptor tyrosine kinase, HTK, on human erythroid progenitor cells. Blood 1997;89:2757-2765
74. Reedquist KA, Ross E, Koop EA, et al. The small GTPase, Rap1, mediates CD31-induced integrin adhesion. J Cell Biol 2000;148:1151-1158
75. Katagiri K, Hattori M, Minato N, Irie S, Takatsu K, Kinashi T. Rap1 is a potent activation signal for leukocyte function-associated antigen 1 distinct from protein kinase C and phosphatidylinositol-3-OH kinase. Mol Cell Biol 2000;20:1956-1969
76. Bertoni A, Tadokoro S, Eto K, et al. Relationships between Rap1b, affinity modulation of integrin alphaIIbbeta3, and the actin cytoskeleton. J Biol Chem 2002;277:25715-25721
77. Eto K, Murphy R, Kerrigan SW, et al. Megakaryocytes derived from embryonic stem cells implicate CalDAG-GEFI in integrin signaling. Proc Natl Acad Sci USA 2002;99:12819-12824
78. Franke B, Akkerman JWN, Bos JL. Rapid Ca2+-mediated activation of Rap1 in human platelets. EMBO J 1997; 16:252-259
79. Woulfe D, Jiang H, Mortensen R, Yang J, Brass LF. Activation of Rap1B by Gi family members in platelets. J Biol Chem 2002;277:23382-23390
80. De Rooij J, Boenink NM, Van Triest M, Cool RH, Wittinghofer A, Bos JL. PDZ-GEF1, a guanine nucleotide exchange factor specific for Rap1 and Rap2. J Biol Chem 1999;274:38125-38130
81. Melaragno MG, Fridell Y-W, Berk BC. The Gas6/Axl system: a novel regulator of vascular cell function. Trends Cardiovasc Med 1999;9:250-253
82. Ishimoto Y, Nakano T. Release of a product of growth arrest-specific gene 6 from rat platelets. FEBS Lett 2000;466:197-199
83. Angelillo-Scherrer A, De Frutos PG, Aparicio C, et al. Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis. Nat Med 2001;7:215-221
84. Stitt TN, Conn G, Gore M, et al. The anticoagulation factor protein and its relative, Gas6, are ligands for the Tyro3/Axl family of receptor tyrosine kinases. Cell 1995;80:661-670
85. Varnum BC, Young C, Elliott G, et al. Axl receptor tyrosine kinase stimulated by the vitamin K-dependent protein encoded by the growth-arrest-specific gene 6. Nature 1995;373:623-626
86. Angelillo-Scherrer A, Charvier S, Plaisance S, et al. Deficiency in one Gas6 receptor (Axl, Sky or Mer) protects mice against thrombosis because of a platelet dysfunction. J Thromb Haemost 2003;1(suppl 1):OC245
87. Jurasz P, Chung AW, Radomski A, Radomski MW. Nonremodeling properties of matrix metalloproteinases: the platelet connection. Circ Res 2002;90:1041-1043
88. Henn V, Slupsky JR, Gräfe M, et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998;391:591-594
89. Henn V, Steinbach S, Buchner K, Presek P, Kroczek RA. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood 2001;98:1047-1054
90. Hermann A, Rauch BH, Braun M, Schror K, Weber AA. Platelet CD40 ligand (CD40L) - subcellular localization, regulation of expression, and inhibition by clopidogrel. Platelets 2001;12:74-82
91. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001;104:487-501
92. Andre P, Prasad KS, Denis CV, et al. CD40L stabilizes arterial thrombi by a beta3 integrin-dependent mechanism. Nat Med 2002;8:247-252
93. Inwald DP, McDowall A, Peters MJ, Callard RE, Klein NJ. CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. Circ Res 2003;92:1041-1048
94. Mach F, Schonbeck U, Sukhova GK, Akinson E, Libby P. Reduction of atherosclerosis in mice by inhibition of CD40 signaling. Nature 1998;394:200-203
95. May AE, Kalsch T, Massberg S, Herouy Y, Schmidt R, Gawaz M. Engagement of glycoprotein IIb/IIIa on platelets upregulates CD40L abd triggers CD40L-dependent matrix degradation by endothelial cells. Circulation 2002;106:2111-2117
96. Crow AR, Leytin V, Starkey AF, Rand ML, Lazarus AH. CD154 (CD40 ligand)-deficient mice exhibit prolonged bleeding time and decreased shear-induced platelet aggregates. J Thromb Haemost 2003;1:850-852
97. MacEwan DJ. TNF receptor subtype signaling: differences and cellular consequences. Cell Signal 2002;14:477-492
98. Inwald DP, Peters MJ, Walshe D, Jones A, Davies EG, Klein NJ. Absence of platelet CD40L identifies patients with X-linked hyper IgM syndrome. Clin Exp Immunol 2000;120:499-502
99. Prasad KS, Andre P, He M, Bao M, Manganello J, Phillips DR. Soluble CD40 ligand induces {beta}3 integrin tyrosine phosphorylation and triggers platelet activation by outside-in signaling. Proc Natl Acad Sci USA 2003;100:12367-12371
100. Heeschen C, Dimmeler S, Hamm CW, et al. Soluble CD40 ligand in acute coronary syndromes. N Engl J Med 2003; 348:1104-1111
101. Anand SX, Viles-Gonzalez JF, Badimon JJ, Cavusoglu E, Marmur JD. Membrane-associated CD40L and sCD40L in atherothrombotic disease. Thromb Haemost 2003;90:377-384
102. Cha JK, Jeong MH, Jang JY, et al. Serial measurement of surface expressions of CD63, P-selectin and CD40 ligand on platelets in atherosclerotic ischemic stroke. A possible role of CD40 ligand on platelets in atherosclerotic ischemic stroke. Cerebrovasc Dis 2003;16:376-382
103. Elhabazi A, Delaire S, Bensussan A, Boumsell L, Bismuth G. Biological activity of soluble CD100. I. The extracellular region of CD100 is released from the surface of T lymphocytes by regulated proteolysis. J Immunol 2001;166:4341-4347
104. Kumanogoh A, Watanabe C, Lee I, et al. Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling. Immunity 2000;13:621-631
105. Ishida I, Kumanogoh A, Suzuki K, Akahani S, Noda K, Kikutani H. Involvement of CD100, a lymphocyte semaphorin, in the activation of the human immune system via CD72: implications for the regulation of immune and inflammatory responses. Int Immunol 2003;15:1027-1034
106. Delaire S, Billard C, Tordjman R, et al. Biological activity of soluble CD100. II. Soluble CD100, similarly to H-SemaIII, inhibits immune cell migration. J Immunol 2001;166:4348-4354
107. Wang X, Kumanogoh A, Watanabe C, Shi W, Yoshida K, Kikutani H. Functional soluble CD100/Sema4D released from activated lymphocytes: possible role in normal and pathologic immune responses. Blood 2001;97:3498-3504
108. Shi W, Kumanogoh A, Watanabe C, et al. The class IV semaphorin CD100 plays nonredundant roles in the immune system: defective B and T cell activation in CD100-deficient mice. Immunity 2000;13:633-642
109. Tamagnone L, Artigiani S, Chen H, et al. Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell 1999;99:71-80
110. Nakayama E, von Hoegen I, Parnes JR. Sequence of the Lyb-2 B-cell differentiation antigen defines a gene superfamily of receptors with inverted membrane orientation. Proc Natl Acad Sci USA 1989;86:1352-1356
111. Ying H, Nakayama E, Robinson WH, Parnes JR. Structure of the mouse CD72 (Lyb-2) gene and its alternatively spliced transcripts. J Immunol 1995;154:2743-2752
112. Adachi T, Flaswinkel H, Yakura H, Reth M, Tsubata T. The B cell surface protein CD72 recruits the tyrosine phosphatase SHP-1 upon tyrosine phosphorylation. J Immunol 1998;160:4662-4665
113. Tamagnone L, Comoglio PM. Signaling by semaphorin receptors: cell guidance and beyond. Trends Cell Biol 2000;10:377-383
114. Zhu L, Prevost N, Lee V, et al. Semaphorin 4D (CD100) is expressed on the surface of human platelets and proteolytically shed during platelet activation. Blood 2003;102:292a
115. Li RY, Ragab A, Gaits F, Ragab-Thomas JM, Chap H. Thrombin-induced redistribution of protein-tyrosine-phosphatases to the cytoskeletal complexes in human platelets. Cell Mol Biol 1994;40:665-675
116. Li RY, Gaits F, Ragab A, Ragab-Thomas JMF, Chap H. Tyrosine phosphorylation of an SH2-containing protein tyrosine phosphatase is coupled to platelet thrombin receptor via a pertussis toxin-sensitive heterotrimeric G-protein. EMBO J 1995;14:2519-2526